<html>
	<head>
		<title>cdc may sell falconbridge (falcf) debt</title>
		<meta name="keywords" content="places canada">
</head>
<body>
	<h3><canada development corp> said it is considering the sale of the 270.8 mln dlrs it holds of falconbridge ltd's 8.5 pct convertible debentures and of its 25 pct holding in <cdc life sciences inc>.     it said it made the disclosure in two prospectuses filed today with the ontario securities commission.     cdc said one prospectus covers a planned issue of units to raise up to 30 mln dlrs for subsidiary canterra energy ltd's 1987 exploration spending. a second prospectus relates to a planned public sale of four mln common shares which cdc sold privately to an unidentified investor in december.     cdc said the unit offering will consist of a maximum of 18,750 units priced at 1,600 dlrs each. each unit will comprise an interest in cdc flow-through limited partnership and common shares of canterra which will be exchanged for cdc common shares.     through a series of transactions, investors will receive 100 common shares of cdc for each unit, representing a price of 16 dlrs a common share. they will also get rights to income tax deductions equal to the price of each unit.     agents for the sale are wood gundy inc and dominion securities inc.                           reuter &#3;</h3>
</body>
</html>